A citation-based method for searching scientific literature

Franklin W Huang, Eran Hodis, Mary Jue Xu, Gregory V Kryukov, Lynda Chin, Levi A Garraway. Science 2013
Times Cited: 1092







List of co-cited articles
759 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


TERT promoter hotspot mutations are recurrent in myxoid liposarcomas but rare in other soft tissue sarcoma entities.
Christian Koelsche, Marcus Renner, Wolfgang Hartmann, Regine Brandt, Burkhard Lehner, Nina Waldburger, Ingo Alldinger, Thomas Schmitt, Gerlinde Egerer, Roland Penzel,[...]. J Exp Clin Cancer Res 2014
50
6

C11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma.
Matthew Parker, Kumarasamypet M Mohankumar, Chandanamali Punchihewa, Ricardo Weinlich, James D Dalton, Yongjin Li, Ryan Lee, Ruth G Tatevossian, Timothy N Phoenix, Radhika Thiruvenkatam,[...]. Nature 2014
350
3

Telomerase Inhibitor Imetelstat in Patients with Essential Thrombocythemia.
Gabriela M Baerlocher, Elisabeth Oppliger Leibundgut, Oliver G Ottmann, Gary Spitzer, Olatoyosi Odenike, Michael A McDevitt, Alexander Röth, Michael Daskalakis, Bart Burington, Monic Stuart,[...]. N Engl J Med 2015
116
3

Telomeres: protecting chromosomes against genome instability.
Roderick J O'Sullivan, Jan Karlseder. Nat Rev Mol Cell Biol 2010
543
3

TERT promoter mutation as an early genetic event activating telomerase in follicular thyroid adenoma (FTA) and atypical FTA.
Na Wang, Tiantian Liu, Anastasios Sofiadis, C Christofer Juhlin, Jan Zedenius, Anders Höög, Catharina Larsson, Dawei Xu. Cancer 2014
71
4

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.
Jianjiong Gao, Bülent Arman Aksoy, Ugur Dogrusoz, Gideon Dresdner, Benjamin Gross, S Onur Sumer, Yichao Sun, Anders Jacobsen, Rileen Sinha, Erik Larsson,[...]. Sci Signal 2013
3

TERT promoter mutations and telomere length in adult malignant gliomas and recurrences.
Barbara Heidenreich, P Sivaramakrishna Rachakonda, Ismail Hosen, Florian Volz, Kari Hemminki, Astrid Weyerbrock, Rajiv Kumar. Oncotarget 2015
54
5

TERT promoter hot spot mutations are frequent in Indian cervical and oral squamous cell carcinomas.
Vilvanathan Vinothkumar, Ganesan Arunkumar, Sundaramoorthy Revathidevi, Kanagaraj Arun, Mayakannan Manikandan, Arunagiri Kuha Deva Magendhra Rao, Kottayasamy Seenivasagam Rajkumar, Chandrasekar Ajay, Ramamurthy Rajaraman, Rajendren Ramani,[...]. Tumour Biol 2016
23
13

Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma.
Jianxin Shi, Xiaohong R Yang, Bari Ballew, Melissa Rotunno, Donato Calista, Maria Concetta Fargnoli, Paola Ghiorzo, Brigitte Bressac-de Paillerets, Eduardo Nagore, Marie Francoise Avril,[...]. Nat Genet 2014
185
3

A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma.
Satoru Yokoyama, Susan L Woods, Glen M Boyle, Lauren G Aoude, Stuart MacGregor, Victoria Zismann, Michael Gartside, Anne E Cust, Rizwan Haq, Mark Harland,[...]. Nature 2011
261
3

Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma.
Lauren G Aoude, Antonia L Pritchard, Carla Daniela Robles-Espinoza, Karin Wadt, Mark Harland, Jiyeon Choi, Michael Gartside, Víctor Quesada, Peter Johansson, Jane M Palmer,[...]. J Natl Cancer Inst 2014
93
3

Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi.
Catherine D Van Raamsdonk, Vladimir Bezrookove, Gary Green, Jürgen Bauer, Lona Gaugler, Joan M O'Brien, Elizabeth M Simpson, Gregory S Barsh, Boris C Bastian. Nature 2009
916
3

Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib.
Jeffrey A Sosman, Kevin B Kim, Lynn Schuchter, Rene Gonzalez, Anna C Pavlick, Jeffrey S Weber, Grant A McArthur, Thomas E Hutson, Stergios J Moschos, Keith T Flaherty,[...]. N Engl J Med 2012
3

The ETS family of oncogenic transcription factors in solid tumours.
Gina M Sizemore, Jason R Pitarresi, Subhasree Balakrishnan, Michael C Ostrowski. Nat Rev Cancer 2017
101
3

Frequency of TERT promoter mutations in primary tumors of the liver.
Alexander Quaas, Theresa Oldopp, Lars Tharun, Catina Klingenfeld, Till Krech, Guido Sauter, Tobias J Grob. Virchows Arch 2014
35
8

Chromatin remodeling: recruitment of histone demethylase RBP2 by Mad1 for transcriptional repression of a Myc target gene, telomerase reverse transcriptase.
Zheng Ge, Wenjuan Li, Na Wang, Cheng Liu, Qingjun Zhu, Magnus Björkholm, Astrid Gruber, Dawei Xu. FASEB J 2010
43
6

Myc activates telomerase.
J Wang, L Y Xie, S Allan, D Beach, G J Hannon. Genes Dev 1998
531
3



Alternative splicing regulation of telomerase: a new paradigm?
Mandy S Wong, Woodring E Wright, Jerry W Shay. Trends Genet 2014
58
5

Pan-cancer analysis identifies telomerase-associated signatures and cancer subtypes.
Zhenhua Luo, Weixu Wang, Feng Li, Zhou Songyang, Xuyang Feng, Changchang Xin, Zhiming Dai, Yuanyan Xiong. Mol Cancer 2019
19
15

The telomerase reverse transcriptase regulates chromatin state and DNA damage responses.
Kenkichi Masutomi, Richard Possemato, Judy M Y Wong, Jennifer L Currier, Zuzana Tothova, Judith B Manola, Shridar Ganesan, Peter M Lansdorp, Kathleen Collins, William C Hahn. Proc Natl Acad Sci U S A 2005
252
3

Telomerase reverse transcriptase regulates DNMT3B expression/aberrant DNA methylation phenotype and AKT activation in hepatocellular carcinoma.
Jingya Yu, Xiaotian Yuan, Louise Sjöholm, Tiantian Liu, Feng Kong, Tomas J Ekström, Magnus Björkholm, Dawei Xu. Cancer Lett 2018
22
13

Ets2 maintains hTERT gene expression and breast cancer cell proliferation by interacting with c-Myc.
Dakang Xu, Julie Dwyer, He Li, Wei Duan, Jun-Ping Liu. J Biol Chem 2008
101
3

Telomerase modulates Wnt signalling by association with target gene chromatin.
Jae-Il Park, Andrew S Venteicher, Ji Yeon Hong, Jinkuk Choi, Sohee Jun, Marina Shkreli, Woody Chang, Zhaojing Meng, Peggie Cheung, Hong Ji,[...]. Nature 2009
428
3

The telomerase reverse transcriptase (hTERT) gene is a direct target of the histone methyltransferase SMYD3.
Cheng Liu, Xiaolei Fang, Zheng Ge, Marit Jalink, Satoru Kyo, Magnus Björkholm, Astrid Gruber, Jan Sjöberg, Dawei Xu. Cancer Res 2007
77
3

Wnt/β-catenin signaling regulates telomerase in stem cells and cancer cells.
Katrin Hoffmeyer, Angelo Raggioli, Stefan Rudloff, Roman Anton, Andreas Hierholzer, Ignacio Del Valle, Kerstin Hein, Riana Vogt, Rolf Kemler. Science 2012
341
3

The 2007 WHO classification of tumours of the central nervous system.
David N Louis, Hiroko Ohgaki, Otmar D Wiestler, Webster K Cavenee, Peter C Burger, Anne Jouvet, Bernd W Scheithauer, Paul Kleihues. Acta Neuropathol 2007
3

Heterogeneity of TERT promoter mutations status in squamous cell carcinomas of different anatomical sites.
Katherine A Cheng, Boaz Kurtis, Sabina Babayeva, Jian Zhuge, Irlna Tantchou, Dongming Cai, Rocco J Lafaro, John T Fallon, Minghao Zhong. Ann Diagn Pathol 2015
23
13

NTRK3 kinase fusions in Spitz tumours.
Iwei Yeh, Meng Kian Tee, Thomas Botton, A Hunter Shain, Alyssa J Sparatta, Alexander Gagnon, Swapna S Vemula, Maria C Garrido, Kenji Nakamaru, Takeshi Isoyama,[...]. J Pathol 2016
71
4

TERT promoter mutations and long telomere length predict poor survival and radiotherapy resistance in gliomas.
Ke Gao, Gang Li, Yiping Qu, Maode Wang, Bo Cui, Meiju Ji, Bingyin Shi, Peng Hou. Oncotarget 2016
41
7

Mutational landscape and significance across 12 major cancer types.
Cyriac Kandoth, Michael D McLellan, Fabio Vandin, Kai Ye, Beifang Niu, Charles Lu, Mingchao Xie, Qunyuan Zhang, Joshua F McMichael, Matthew A Wyczalkowski,[...]. Nature 2013
3

Improved survival with vemurafenib in melanoma with BRAF V600E mutation.
Paul B Chapman, Axel Hauschild, Caroline Robert, John B Haanen, Paolo Ascierto, James Larkin, Reinhard Dummer, Claus Garbe, Alessandro Testori, Michele Maio,[...]. N Engl J Med 2011
3

High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions.
Jean Charles Nault, Maxime Mallet, Camilla Pilati, Julien Calderaro, Paulette Bioulac-Sage, Christophe Laurent, Alexis Laurent, Daniel Cherqui, Charles Balabaud, Jessica Zucman-Rossi. Nat Commun 2013
359
3

Mutations of the TERT promoter are common in basal cell carcinoma and squamous cell carcinoma.
Glynis A Scott, Todd S Laughlin, Paul G Rothberg. Mod Pathol 2014
65
4

Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activity.
Isabelle Guilleret, Pu Yan, Fabienne Grange, Richard Braunschweig, Fred T Bosman, Jean Benhattar. Int J Cancer 2002
172
3

Integrative genomics viewer.
James T Robinson, Helga Thorvaldsdóttir, Wendy Winckler, Mitchell Guttman, Eric S Lander, Gad Getz, Jill P Mesirov. Nat Biotechnol 2011
3

The Reactome Pathway Knowledgebase.
Antonio Fabregat, Steven Jupe, Lisa Matthews, Konstantinos Sidiropoulos, Marc Gillespie, Phani Garapati, Robin Haw, Bijay Jassal, Florian Korninger, Bruce May,[...]. Nucleic Acids Res 2018
3


Gene ontology: tool for the unification of biology. The Gene Ontology Consortium.
M Ashburner, C A Ball, J A Blake, D Botstein, H Butler, J M Cherry, A P Davis, K Dolinski, S S Dwight, J T Eppig,[...]. Nat Genet 2000
3

Integrative analysis of 111 reference human epigenomes.
Anshul Kundaje, Wouter Meuleman, Jason Ernst, Misha Bilenky, Angela Yen, Alireza Heravi-Moussavi, Pouya Kheradpour, Zhizhuo Zhang, Jianrong Wang, Michael J Ziller,[...]. Nature 2015
3

Pan-cancer screen for mutations in non-coding elements with conservation and cancer specificity reveals correlations with expression and survival.
Henrik Hornshøj, Morten Muhlig Nielsen, Nicholas A Sinnott-Armstrong, Michał P Świtnicki, Malene Juul, Tobias Madsen, Richard Sallari, Manolis Kellis, Torben Ørntoft, Asger Hobolth,[...]. NPJ Genom Med 2018
31
9

OncodriveFML: a general framework to identify coding and non-coding regions with cancer driver mutations.
Loris Mularoni, Radhakrishnan Sabarinathan, Jordi Deu-Pons, Abel Gonzalez-Perez, Núria López-Bigas. Genome Biol 2016
97
3

Discovery of Cancer Driver Long Noncoding RNAs across 1112 Tumour Genomes: New Candidates and Distinguishing Features.
Andrés Lanzós, Joana Carlevaro-Fita, Loris Mularoni, Ferran Reverter, Emilio Palumbo, Roderic Guigó, Rory Johnson. Sci Rep 2017
50
6

Pan-cancer patterns of somatic copy number alteration.
Travis I Zack, Stephen E Schumacher, Scott L Carter, Andre D Cherniack, Gordon Saksena, Barbara Tabak, Michael S Lawrence, Cheng-Zhong Zhsng, Jeremiah Wala, Craig H Mermel,[...]. Nat Genet 2013
961
3

The landscape of somatic copy-number alteration across human cancers.
Rameen Beroukhim, Craig H Mermel, Dale Porter, Guo Wei, Soumya Raychaudhuri, Jerry Donovan, Jordi Barretina, Jesse S Boehm, Jennifer Dobson, Mitsuyoshi Urashima,[...]. Nature 2010
3

Pan-cancer analysis of somatic copy-number alterations implicates IRS4 and IGF2 in enhancer hijacking.
Joachim Weischenfeldt, Taronish Dubash, Alexandros P Drainas, Balca R Mardin, Yuanyuan Chen, Adrian M Stütz, Sebastian M Waszak, Graziella Bosco, Ann Rita Halvorsen, Benjamin Raeder,[...]. Nat Genet 2017
155
3

Universal Patterns of Selection in Cancer and Somatic Tissues.
Iñigo Martincorena, Keiran M Raine, Moritz Gerstung, Kevin J Dawson, Kerstin Haase, Peter Van Loo, Helen Davies, Michael R Stratton, Peter J Campbell. Cell 2017
362
3

Comprehensive Characterization of Cancer Driver Genes and Mutations.
Matthew H Bailey, Collin Tokheim, Eduard Porta-Pardo, Sohini Sengupta, Denis Bertrand, Amila Weerasinghe, Antonio Colaprico, Michael C Wendl, Jaegil Kim, Brendan Reardon,[...]. Cell 2018
144
3

Insertions and Deletions Target Lineage-Defining Genes in Human Cancers.
Marcin Imielinski, Guangwu Guo, Matthew Meyerson. Cell 2017
47
6


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.